pevonedistat, azacitidine and venetoclax triplet therapy for aml, mds and cmml
Published 1 year ago • 138 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
3:03
venetoclax and 5-azacytidine for the treatment of mds and cmml
-
1:59
phase i study of pevonedistat, azacitidine, and venetoclax in patients with r/r aml
-
1:46
tagraxofusp combined with azacitidine and venetoclax in the treatment of bpdcn and aml
-
5:36
venetoclax and azacitidine in mds patients
-
1:40
pivekimab sunirine in combination with venetoclax and azacitidine for cd123-positive aml
-
2:50
pevonedistat, venetoclax and azacitidine for older aml patients
-
1:37
a phase i/ii trial of seclidemstat in combination with azacitidine for patients with mds and cmml
-
7:38
asco/eha myeloma updates 2024 | claudio cerchione, md | eha 2024
-
12:05
venetoclax combinations, safety and efficacy
-
6:58
venetoclax plus azacitidine for higher-risk mds
-
1:31
pevaz update: pevonedistat & azacitidine in r/r mds and mds/mpn after dnmti failure
-
0:44
mds: an update on pevonedistat plus azacitidine
-
0:44
predictors of poor response to azacitidine, venetoclax, and magrolimab in tp53-mutated aml
-
1:25
the potential of triplet regimens combining btkis with venetoclax and obinutuzumab in cll
-
3:53
investigating the combination of pivekimab sunirine, azacitidine & venetoclax in r/r aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:47
pevonedistat with azacitidine for high-risk mds
-
5:52
venetoclax in combination with azacitidine for patients with treatment-naïve hr-mds
-
2:27
emavusertib in combination with azacitidine and venetoclax in patients with aml
-
2:45
the addition of venetoclax to hmas for the treatment of cmml: a retrospective psm analysis
-
1:36
eprenetapopt plus venetoclax and azacitidine in the treatment of tp53-mutated aml
-
1:48
azacitidine and venetoclax maintenance post allosct in high-risk t-all